Global Performance Enhancing Drugs Market – Industry Trends and Forecast to 2029 databridgemarketresearch.com

Data Bridge Market Research analyses that the performance enhancing drugs market will exhibit a CAGR of around 5.30% for the forecast period of 2022-2029. Rising prevalence of chronic diseases and disorders, increased focus on research and development proficiencies, growing adoption of advanced healthcare technologies, rising use of anabolic steroids amongst the target audience and patients having medical histories and rising expenditure for the development of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of performance enhancing drugs market.